These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18566029)

  • 21. Latitudinal variation in incidence and type of first central nervous system demyelinating events.
    Taylor BV; Lucas RM; Dear K; Kilpatrick TJ; Pender MP; van der Mei IA; Chapman C; Coulthard A; Dwyer T; McMichael AJ; Valery PC; Williams D; Ponsonby AL
    Mult Scler; 2010 Apr; 16(4):398-405. PubMed ID: 20167594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis.
    Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN
    Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Geographical variations in sex ratio trends over time in multiple sclerosis.
    Trojano M; Lucchese G; Graziano G; Taylor BV; Simpson S; Lepore V; Grand'maison F; Duquette P; Izquierdo G; Grammond P; Amato MP; Bergamaschi R; Giuliani G; Boz C; Hupperts R; Van Pesch V; Lechner-Scott J; Cristiano E; Fiol M; Oreja-Guevara C; Saladino ML; Verheul F; Slee M; Paolicelli D; Tortorella C; D'Onghia M; Iaffaldano P; Direnzo V; Butzkueven H;
    PLoS One; 2012; 7(10):e48078. PubMed ID: 23133550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epilepsy in multiple sclerosis: A nationwide population-based register study.
    Burman J; Zelano J
    Neurology; 2017 Dec; 89(24):2462-2468. PubMed ID: 29117950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of secondary progressive multiple sclerosis: A longitudinal study.
    Fambiatos A; Jokubaitis V; Horakova D; Kubala Havrdova E; Trojano M; Prat A; Girard M; Duquette P; Lugaresi A; Izquierdo G; Grand'Maison F; Grammond P; Sola P; Ferraro D; Alroughani R; Terzi M; Hupperts R; Boz C; Lechner-Scott J; Pucci E; Bergamaschi R; Van Pesch V; Ozakbas S; Granella F; Turkoglu R; Iuliano G; Spitaleri D; McCombe P; Solaro C; Slee M; Ampapa R; Soysal A; Petersen T; Sanchez-Menoyo JL; Verheul F; Prevost J; Sidhom Y; Van Wijmeersch B; Vucic S; Cristiano E; Saladino ML; Deri N; Barnett M; Olascoaga J; Moore F; Skibina O; Gray O; Fragoso Y; Yamout B; Shaw C; Singhal B; Shuey N; Hodgkinson S; Altintas A; Al-Harbi T; Csepany T; Taylor B; Hughes J; Jun JK; van der Walt A; Spelman T; Butzkueven H; Kalincik T
    Mult Scler; 2020 Jan; 26(1):79-90. PubMed ID: 31397221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epileptic seizures, cranial neuralgias and paroxysmal symptoms in remitting and progressive multiple sclerosis.
    Eriksson M; Ben-Menachem E; Andersen O
    Mult Scler; 2002 Dec; 8(6):495-9. PubMed ID: 12474990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.
    Sumelahti ML; Tienari PJ; Hakama M; Wikström J
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):25-8. PubMed ID: 12486261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical course of progressive multiple sclerosis in Brazilian patients.
    Vasconcelos CC; Miranda-Santos CM; Alvarenga RM
    Neuroepidemiology; 2006; 26(4):233-9. PubMed ID: 16707908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of multiple sclerosis in Buenos Aires, Argentina using the capture-recapture method.
    Cristiano E; Patrucco L; Rojas JI; Cáceres F; Carrá A; Correale J; Garcea O; Gold L; Tessler J; Kremenchutzky M
    Eur J Neurol; 2009 Feb; 16(2):183-7. PubMed ID: 19138341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional study.
    Miclea A; Salmen A; Zoehner G; Diem L; Kamm CP; Chaloulos-Iakovidis P; Miclea M; Briner M; Kilidireas K; Stefanis L; Chan A; Evangelopoulos ME; Hoepner R
    CNS Neurosci Ther; 2019 Apr; 25(4):527-531. PubMed ID: 30411534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study.
    Zivadinov R; Iona L; Monti-Bragadin L; Bosco A; Jurjevic A; Taus C; Cazzato G; Zorzon M
    Neuroepidemiology; 2003; 22(1):65-74. PubMed ID: 12566956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple sclerosis: report on 200 cases from Iran.
    Kalanie H; Gharagozli K; Kalanie AR
    Mult Scler; 2003 Feb; 9(1):36-8. PubMed ID: 12617266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing prevalence of multiple sclerosis in Buenos Aires, Argentina.
    Cristiano E; Patrucco L; Miguez J; Giunta D; Correale J; Fiol M; Ysrraelit MC; Cáceres F; Liguori NF; Saladino ML; Garcea O; Silva B; Alonso R; Carrá A; Curbelo MC; Martinez A; Steinberg J; Giachello S; Melcom MO; Rojas JI
    Mult Scler Relat Disord; 2016 Sep; 9():91-4. PubMed ID: 27645351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-World Safety and Patient Profile of Fingolimod in Relapsing-Remitting Multiple Sclerosis: A Prospective Analysis in Buenos Aires, Argentina.
    Rojas JI; Patrucco L; Miguez J; Cristiano E
    Clin Neuropharmacol; 2017; 40(6):251-254. PubMed ID: 28976408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal epidemiology of multiple sclerosis in Townsville, Queensland, Australia, 2012-2022.
    Simpson-Yap S; Maddox D; Reece J; Lechner-Scott J; Shaw C; Taylor B; Kalincik T; van der Walt A; Boggild M
    Mult Scler Relat Disord; 2023 Sep; 77():104845. PubMed ID: 37442078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population.
    Cocco E; Sardu C; Murru R; Frau J; Lorefice L; Mamusa E; Contu P; Marrosu MG
    Mult Scler; 2009 Sep; 15(9):1030-6. PubMed ID: 19625333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of satellite data to measure ultraviolet-B penetrance and its potential association with age of multiple sclerosis onset.
    Amram O; Schuurman N; Randall E; Zhu F; Saeedi J; Rieckmann P; Yee I; Tremlett H
    Mult Scler Relat Disord; 2018 Apr; 21():30-34. PubMed ID: 29455071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking and multiple sclerosis: a matter of global importance.
    Handel AE; Ramagopalan SV
    Neuroepidemiology; 2011; 37(3-4):243-4. PubMed ID: 22156616
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiple sclerosis in Pakistan.
    Wasay M; Ali S; Khatri IA; Hassan A; Asif M; Zakiullah N; Ahmed A; Malik A; Khealani B; Haq A; Fredrikson S
    Mult Scler; 2007 Jun; 13(5):668-9. PubMed ID: 17548448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry.
    Lo AC; Hadjimichael O; Vollmer TL
    Mult Scler; 2005 Feb; 11(1):33-40. PubMed ID: 15732264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.